Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences

Clinical Cancer Research

Volumn 13, Issue 7, 2007, Pages 2005-2013

  Kriangkum, Jitra ^a   Taylor, Brian J ^a   Treon, Steven P ^b   Mant, Michael J ^a   Reiman, Tony ^a   Belch, Andrew R ^a   Pilarski, Linda M ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c CROSS CANCER INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARAPROTEIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ALLELIC EXCLUSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANCER CELL; CELL LINEAGE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC VARIABILITY; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE CLONE; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; SOMATIC MUTATION; TISSUE DISTRIBUTION; VDJ GENE; WALDENSTROEM MACROGLOBULINEMIA;

AGED; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINEAGE; CELL SEPARATION; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; ELECTROPHORESIS, CAPILLARY; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WALDENSTROM MACROGLOBULINEMIA;

EID: 34247547763     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2788     Document Type: Article

References (31)

1. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003;30:110-5.
2. Owen RG, Johnson SA, Morgan GJ. Waldenstrom's macroglobulinaemia: laboratory diagnosis and treatment Hematol Oncol 2000;18:41-9.
3. Papamichael D, Norton AJ, Foran JM, et al. Immunocytoma: a retrospective analysis from St Bartholomew's Hospital - 1972 to 1996. J Clin Oncol 1999;17: 2847-53.
4. Hunter ZR, Branagan AR, Manning R, et al. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia. Clin Lymphoma 2005;5:246-9.
5. Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM. Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood 2004;104:2134-42.
6. Kriangkum J, Taylor BJ, Mant MJ, Treon SP, Belch AR, Pilarski LM. The malignant clone in Waldenstrom's macroglobulinemia. Semin Oncol 2003;30:132-5.
7. Kriangkum J, Taylor BJ, Strachan E, et al. Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. Blood 2006;107:2920-7.
8. Kriangkum J, Taylor BJ, Reiman T, Belch AR, Pilarski LM. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor? Clin Lymphoma 2005;5:217-9.
9. Walsh SH, Laurell A, Sundstrom G, Roos G, Sundstrom C, Rosenquist R. Lymphoplasmacytic lymphoma/ Waldenstrom's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation. Leuk Res 2005;29:729-34.
10. Sahota SS, Forconi F, Ottensmeier CH, Stevenson FK. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia. Semin Oncol 2003;30: 136-41.
11. Sahota SS, Forconi F, Ottensmeier CH, et al. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood 2002;100:1505-7.
12. Levy R, Warnke R, Dorfman RF, Haimovich J. The monoclonality of human B-cell lymphomas. J Exp Med 1977;145:1014-28.
13. Cleary ML, Chao J, Warnke R, Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci U S A 1984;81: 593-7.
14. Yunis JJ. The chromosomal basis of human neoplasia. Science 1983;221:227-36.
15. Scrideli CA, Defavery R, Bernardes JE, Tone LG. Prognostic significance of bi/oligoclonality in childhood acute lymphoblastic leukemia as determined by polymerase chain reaction. Sao Paulo Med J 2001; 119:175-80.
16. Sklar J, Cleary ML, Thielemans K, Gralow J, Warnke R, Levy R. Biclonal B-cell lymphoma. N Engl J Med 1984;311:20-7.
17. Sanchez ML, Almeida J, Gonzalez D, et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 2003;102:2994-3002.
18. Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance: a review. Immunol Rev 2003;194:112-39.
19. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-20.
20. Lima M, Teixeira Mdos A, Fonseca S, et al. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies. Blood Cells Mol Dis 2000;26:634-45.
21. Bonewald L, Virella G, Wang AC. Evidence for the biclonal nature of a Waldenstrom's macroglobulinemia. Clin Chim Acta 1985;146:53-63.
22. Fine JM, Gorin NC, Gendre JP, Petitpierre JC, Labro-Bryskier MT, Lambin P. Simultaneous occurrence of clinical manifestations of myeloma and Waldenstrom's macroglobulinemia with monoclonal IgG Lambda and IgM κ in a single patient. Acta Med Scand 1981;209:229-34.
23. Ciric B, VanKeulen V, Rodriguez M, Kyle RA, Gertz MA, Pease LR. Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. Blood 2001;97:321-3.
24. Schulz R, David D, Farkas DH, Crisan D. Molecular analysis in a patient with Waldenstrom's macroglobulinemia reveals a rare case of biclonality. Mol Diagn 1996;1:159-66.
25. Lefranc MP. IMGT databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr. Leukemia 2003;17: 260-6.
26. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997;158:235-46.
27. Cleary ML, Galili N, Trela M, Levy R, Sklar J. Single cell origin of bigenotypic and biphenotypic B cell proliferations in human follicular lymphomas. J Exp Med 1988;167:582-97.
28. Ackroyd S, O'Connor SJ, Owen RG. Rarity of IgH translocations in Waldenstrom macroglobulinemia. Cancer Genet Cytogenet 2005;163:77-80.
29. Noppe SM, Heirman C, Bakkus MH, Brissinck J, Schots R, Thielemans K. The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism. Br J Haematol 1999;107: 625-40.
30. Ottensmeier CH, Thompsett AR, Zhu D, Wilkins BS, Sweetenham JW, Stevenson FK. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998;91:4292-9.
31. Weber D, Treon SP, Emmanouilides C, et al. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003;30:127-31.